By Dr. Jeffrey Peng, MD · Published March 4, 2026 · 8 min read Watch the Full Video GLP-1 receptor agonists such as Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) have transformed the landscape of medical weight loss. Originally developed for type 2 diabetes management, these medications are now generating excitement for an entirely different reason: their potential role in treating arthritis . Emerging clinical evidence suggests that GLP-1 agonists may not only r